Observational study on chronic kidney disease in Alsace
Chronic Kidney Disease - REAL Life Study in Alsace
University Hospital, Strasbourg, France · NCT05527626
This study is trying to learn more about adults with severe chronic kidney disease in Alsace to see what factors affect their health and how to better manage their condition before they need dialysis or a transplant.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France (other) |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT05527626 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on chronic kidney disease (CKD) in the Alsace region of France, aiming to gather real-life data on patients with severe CKD. It seeks to identify patient characteristics and factors influencing the progression of CKD and its complications, which are crucial for improving management strategies before patients require dialysis or transplantation. The study includes adults aged 18 and older with a glomerular filtration rate (GFR) of less than 30 ml/min/1.73 m² and who consent to data reuse for research purposes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with severe chronic kidney disease (stage 4 or non-dialysis stage 5).
Not a fit: Patients who have expressed opposition to participating in the study will not benefit from the findings.
Why it matters
Potential benefit: If successful, this study could enhance the management and treatment of chronic kidney disease, potentially delaying the need for dialysis or transplantation.
How similar studies have performed: Other studies focusing on real-life data in chronic kidney disease have shown promise in improving patient management, indicating that this approach is both relevant and potentially beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Major subject (≥18 years) * Subject included in the MRC package (GFR \<30 ml/min/1.73 m2) * Subject who has not expressed opposition, after information, to the reuse of his or her data for the purpose of this research Exclusion criteria: \- Subject having expressed his opposition to participate in the study
Where this trial is running
Strasbourg
- Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France — Strasbourg, France (RECRUITING)
Study contacts
- Principal investigator: Peggy PERRIN, MD — Service Néphrologie-Dialyse-Transplantation - CHU de Strasbourg - France
- Study coordinator: Peggy PERRIN, MD
- Email: peggy.perrin@chru-strasbourg.fr
- Phone: 33 3 69 55 13 26
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Chronic Kidney Diseases, Kidney, Chronic Disease, Chronic Kidney Disease